CLINICAL_TRIALS
trial_result
· 2025-05-15
Clinical Trial Update: A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD [Phase 2]
Summary
A biomarker-guided, randomized, placebo-controlled Phase 2 trial evaluating Liafensine for treatment-resistant depression has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denovo Biopharma LLC | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED | Results posted: 2025-05-15